Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 48

1.

Prospects for Fungal Bioremediation of Acidic Radioactive Waste Sites: Characterization and Genome Sequence of Rhodotorula taiwanensis MD1149.

Tkavc R, Matrosova VY, Grichenko OE, Gostinčar C, Volpe RP, Klimenkova P, Gaidamakova EK, Zhou CE, Stewart BJ, Lyman MG, Malfatti SA, Rubinfeld B, Courtot M, Singh J, Dalgard CL, Hamilton T, Frey KG, Gunde-Cimerman N, Dugan L, Daly MJ.

Front Microbiol. 2018 Jan 8;8:2528. doi: 10.3389/fmicb.2017.02528. eCollection 2017.

2.

Rhodotorula taiwanensis MD1149 produces hypoacetylated PEFA compounds with increased surface activity compared to Rhodotorula babjevae MD1169.

Lyman M, Rubinfeld B, Leif R, Mulcahy H, Dugan L, Souza B.

PLoS One. 2018 Jan 2;13(1):e0190373. doi: 10.1371/journal.pone.0190373. eCollection 2018.

3.

Development and Translational Application of an Integrated, Mechanistic Model of Antibody-Drug Conjugate Pharmacokinetics.

Sukumaran S, Zhang C, Leipold DD, Saad OM, Xu K, Gadkar K, Samineni D, Wang B, Milojic-Blair M, Carrasco-Triguero M, Rubinfeld B, Fielder P, Lin K, Ramanujan S.

AAPS J. 2017 Jan;19(1):130-140. doi: 10.1208/s12248-016-9993-z. Epub 2016 Sep 27.

PMID:
27679517
4.

ImmunoPET helps predicting the efficacy of antibody-drug conjugates targeting TENB2 and STEAP1.

Williams SP, Ogasawara A, Tinianow JN, Flores JE, Kan D, Lau J, Go M, Vanderbilt AN, Gill HS, Miao L, Goldsmith J, Rubinfeld B, Mao W, Firestein R, Yu SF, Marik J, Terwisscha van Scheltinga AG.

Oncotarget. 2016 May 3;7(18):25103-12. doi: 10.18632/oncotarget.8390.

5.

Preclinical Development of an Anti-NaPi2b (SLC34A2) Antibody-Drug Conjugate as a Therapeutic for Non-Small Cell Lung and Ovarian Cancers.

Lin K, Rubinfeld B, Zhang C, Firestein R, Harstad E, Roth L, Tsai SP, Schutten M, Xu K, Hristopoulos M, Polakis P.

Clin Cancer Res. 2015 Nov 15;21(22):5139-50. doi: 10.1158/1078-0432.CCR-14-3383. Epub 2015 Jul 8.

6.

Evolutionary divergence in the catalytic activity of the CAM-1, ROR1 and ROR2 kinase domains.

Bainbridge TW, DeAlmeida VI, Izrael-Tomasevic A, Chalouni C, Pan B, Goldsmith J, Schoen AP, Quiñones GA, Kelly R, Lill JR, Sandoval W, Costa M, Polakis P, Arnott D, Rubinfeld B, Ernst JA.

PLoS One. 2014 Jul 16;9(7):e102695. doi: 10.1371/journal.pone.0102695. eCollection 2014.

7.

HectD1 E3 ligase modifies adenomatous polyposis coli (APC) with polyubiquitin to promote the APC-axin interaction.

Tran H, Bustos D, Yeh R, Rubinfeld B, Lam C, Shriver S, Zilberleyb I, Lee MW, Phu L, Sarkar AA, Zohn IE, Wertz IE, Kirkpatrick DS, Polakis P.

J Biol Chem. 2013 Feb 8;288(6):3753-67. doi: 10.1074/jbc.M112.415240. Epub 2012 Dec 31.

8.

Impact of drug conjugation on pharmacokinetics and tissue distribution of anti-STEAP1 antibody-drug conjugates in rats.

Boswell CA, Mundo EE, Zhang C, Bumbaca D, Valle NR, Kozak KR, Fourie A, Chuh J, Koppada N, Saad O, Gill H, Shen BQ, Rubinfeld B, Tibbitts J, Kaur S, Theil FP, Fielder PJ, Khawli LA, Lin K.

Bioconjug Chem. 2011 Oct 19;22(10):1994-2004. doi: 10.1021/bc200212a. Epub 2011 Oct 3.

PMID:
21913715
9.

Wnt isoform-specific interactions with coreceptor specify inhibition or potentiation of signaling by LRP6 antibodies.

Gong Y, Bourhis E, Chiu C, Stawicki S, DeAlmeida VI, Liu BY, Phamluong K, Cao TC, Carano RA, Ernst JA, Solloway M, Rubinfeld B, Hannoush RN, Wu Y, Polakis P, Costa M.

PLoS One. 2010 Sep 13;5(9):e12682. doi: 10.1371/journal.pone.0012682.

10.

The soluble wnt receptor Frizzled8CRD-hFc inhibits the growth of teratocarcinomas in vivo.

DeAlmeida VI, Miao L, Ernst JA, Koeppen H, Polakis P, Rubinfeld B.

Cancer Res. 2007 Jun 1;67(11):5371-9.

11.

Identification and immunotherapeutic targeting of antigens induced by chemotherapy.

Rubinfeld B, Upadhyay A, Clark SL, Fong SE, Smith V, Koeppen H, Ross S, Polakis P.

Nat Biotechnol. 2006 Feb;24(2):205-9. Epub 2006 Jan 29.

PMID:
16444269
12.

Synergistic induction of tumor antigens by Wnt-1 signaling and retinoic acid revealed by gene expression profiling.

Tice DA, Szeto W, Soloviev I, Rubinfeld B, Fong SE, Dugger DL, Winer J, Williams PM, Wieand D, Smith V, Schwall RH, Pennica D, Polakis P.

J Biol Chem. 2002 Apr 19;277(16):14329-35. Epub 2002 Feb 6.

13.

Axin-dependent phosphorylation of the adenomatous polyposis coli protein mediated by casein kinase 1epsilon.

Rubinfeld B, Tice DA, Polakis P.

J Biol Chem. 2001 Oct 19;276(42):39037-45. Epub 2001 Aug 3.

14.

Overexpression of the retinoic acid-responsive gene Stra6 in human cancers and its synergistic induction by Wnt-1 and retinoic acid.

Szeto W, Jiang W, Tice DA, Rubinfeld B, Hollingshead PG, Fong SE, Dugger DL, Pham T, Yansura DG, Wong TA, Grimaldi JC, Corpuz RT, Singh JS, Frantz GD, Devaux B, Crowley CW, Schwall RH, Eberhard DA, Rastelli L, Polakis P, Pennica D.

Cancer Res. 2001 May 15;61(10):4197-205.

15.

From genes to proteins: high-throughput expression and purification of the human proteome.

Albala JS, Franke K, McConnell IR, Pak KL, Folta PA, Rubinfeld B, Davies AH, Lennon GG, Clark R.

J Cell Biochem. 2000 Oct 20;80(2):187-91.

PMID:
11074586
16.

Defects in the regulation of beta-catenin in colorectal cancer.

Polakis P, Hart M, Rubinfeld B.

Adv Exp Med Biol. 1999;470:23-32. Review.

PMID:
10709671
17.

The metalloproteinase matrilysin is a target of beta-catenin transactivation in intestinal tumors.

Crawford HC, Fingleton BM, Rudolph-Owen LA, Goss KJ, Rubinfeld B, Polakis P, Matrisian LM.

Oncogene. 1999 May 6;18(18):2883-91.

18.

The F-box protein beta-TrCP associates with phosphorylated beta-catenin and regulates its activity in the cell.

Hart M, Concordet JP, Lassot I, Albert I, del los Santos R, Durand H, Perret C, Rubinfeld B, Margottin F, Benarous R, Polakis P.

Curr Biol. 1999 Feb 25;9(4):207-10.

19.
20.

Downregulation of beta-catenin by human Axin and its association with the APC tumor suppressor, beta-catenin and GSK3 beta.

Hart MJ, de los Santos R, Albert IN, Rubinfeld B, Polakis P.

Curr Biol. 1998 May 7;8(10):573-81.

21.

Induction of a beta-catenin-LEF-1 complex by wnt-1 and transforming mutants of beta-catenin.

Porfiri E, Rubinfeld B, Albert I, Hovanes K, Waterman M, Polakis P.

Oncogene. 1997 Dec 4;15(23):2833-9.

22.
23.

Induction of phosphorylation on BRCA1 during the cell cycle and after DNA damage.

Thomas JE, Smith M, Tonkinson JL, Rubinfeld B, Polakis P.

Cell Growth Differ. 1997 Jul;8(7):801-9.

24.

Stabilization of beta-catenin by genetic defects in melanoma cell lines.

Rubinfeld B, Robbins P, El-Gamil M, Albert I, Porfiri E, Polakis P.

Science. 1997 Mar 21;275(5307):1790-2.

25.
26.
27.

Subcellular localization and analysis of apparent 180-kDa and 220-kDa proteins of the breast cancer susceptibility gene, BRCA1.

Thomas JE, Smith M, Rubinfeld B, Gutowski M, Beckmann RP, Polakis P.

J Biol Chem. 1996 Nov 8;271(45):28630-5.

29.

Binding of GSK3beta to the APC-beta-catenin complex and regulation of complex assembly.

Rubinfeld B, Albert I, Porfiri E, Fiol C, Munemitsu S, Polakis P.

Science. 1996 May 17;272(5264):1023-6.

PMID:
8638126
30.

Wnt-1 regulates free pools of catenins and stabilizes APC-catenin complexes.

Papkoff J, Rubinfeld B, Schryver B, Polakis P.

Mol Cell Biol. 1996 May;16(5):2128-34.

31.

Regulation of intracellular beta-catenin levels by the adenomatous polyposis coli (APC) tumor-suppressor protein.

Munemitsu S, Albert I, Souza B, Rubinfeld B, Polakis P.

Proc Natl Acad Sci U S A. 1995 Mar 28;92(7):3046-50.

32.

The APC protein and E-cadherin form similar but independent complexes with alpha-catenin, beta-catenin, and plakoglobin.

Rubinfeld B, Souza B, Albert I, Munemitsu S, Polakis P.

J Biol Chem. 1995 Mar 10;270(10):5549-55.

33.

Purification of baculovirus-produced Rap1 GTPase-activating protein.

Rubinfeld B, Polakis P.

Methods Enzymol. 1995;255:31-8. No abstract available.

PMID:
8524116
34.

Molecular cloning of a novel mitogen-inducible nuclear protein with a Ran GTPase-activating domain that affects cell cycle progression.

Hattori M, Tsukamoto N, Nur-e-Kamal MS, Rubinfeld B, Iwai K, Kubota H, Maruta H, Minato N.

Mol Cell Biol. 1995 Jan;15(1):552-60.

35.

The APC gene product associates with microtubules in vivo and promotes their assembly in vitro.

Munemitsu S, Souza B, Müller O, Albert I, Rubinfeld B, Polakis P.

Cancer Res. 1994 Jul 15;54(14):3676-81.

36.

The RAP1GA1 locus for human Rap1-GTPase activating protein 1 maps to chromosome 1p36.1-->p35.

Weiss J, Rubinfeld B, Polakis PG, McCormick F, Cavenee WK, Arden KC.

Cytogenet Cell Genet. 1994;66(1):18-21.

PMID:
8275700
37.

Association of the APC gene product with beta-catenin.

Rubinfeld B, Souza B, Albert I, Müller O, Chamberlain SH, Masiarz FR, Munemitsu S, Polakis P.

Science. 1993 Dec 10;262(5140):1731-4.

PMID:
8259518
38.

RapV12 antagonizes Ras-dependent activation of ERK1 and ERK2 by LPA and EGF in Rat-1 fibroblasts.

Cook SJ, Rubinfeld B, Albert I, McCormick F.

EMBO J. 1993 Sep;12(9):3475-85.

39.

Localization of the rap1GAP catalytic domain and sites of phosphorylation by mutational analysis.

Rubinfeld B, Crosier WJ, Albert I, Conroy L, Clark R, McCormick F, Polakis P.

Mol Cell Biol. 1992 Oct;12(10):4634-42.

40.

Mono- and bi-phasic Salmonella typhi: genetic homogeneity and distinguishing characteristics.

Moshitch S, Doll L, Rubinfeld BZ, Stocker BA, Schoolnik GK, Gafni Y, Frankel G.

Mol Microbiol. 1992 Sep;6(18):2589-97.

PMID:
1360138
41.

Phosphorylation of rap1GAP in vivo and by cAMP-dependent kinase and the cell cycle p34cdc2 kinase in vitro.

Polakis P, Rubinfeld B, McCormick F.

J Biol Chem. 1992 May 25;267(15):10780-5.

42.

A synthetic peptide corresponding to a sequence in the GTPase activating protein inhibits p21ras stimulation and promotes guanine nucleotide exchange.

Rubinfeld B, Wong G, Bekesi E, Wood A, Heimer E, McCormick F, Polakis P.

Int J Pept Protein Res. 1991 Jul;38(1):47-53.

PMID:
1938104
43.

Molecular cloning of a GTPase activating protein specific for the Krev-1 protein p21rap1.

Rubinfeld B, Munemitsu S, Clark R, Conroy L, Watt K, Crosier WJ, McCormick F, Polakis P.

Cell. 1991 Jun 14;65(6):1033-42.

PMID:
1904317
44.

Purification of a plasma membrane-associated GTPase-activating protein specific for rap1/Krev-1 from HL60 cells.

Polakis PG, Rubinfeld B, Evans T, McCormick F.

Proc Natl Acad Sci U S A. 1991 Jan 1;88(1):239-43.

45.

Molecular cloning of two types of GAP complementary DNA from human placenta.

Trahey M, Wong G, Halenbeck R, Rubinfeld B, Martin GA, Ladner M, Long CM, Crosier WJ, Watt K, Koths K, et al.

Science. 1988 Dec 23;242(4886):1697-700.

PMID:
3201259
46.

Interaction of ras p21 proteins with GTPase activating protein.

McCormick F, Adari H, Trahey M, Halenbeck R, Koths K, Martin GA, Crosier WJ, Watt K, Rubinfeld B, Wong G.

Cold Spring Harb Symp Quant Biol. 1988;53 Pt 2:849-54. No abstract available.

PMID:
2855502
47.

Tight genetic linkage of a glucosyltransferase and dextranase of Streptococcus mutans GS-5.

Burne RA, Rubinfeld B, Bowen WH, Yasbin RE.

J Dent Res. 1986 Dec;65(12):1392-401.

PMID:
2946734
48.

Cloning and expression of a Streptococcus mutans glucosyltransferase gene in Bacillus subtilis.

Burne RA, Rubinfeld B, Bowen WH, Yasbin RE.

Gene. 1986;47(2-3):201-9.

PMID:
2951298

Supplemental Content

Loading ...
Support Center